Guanosine Triphosphate

KRAS proto-oncogene, GTPase ; Homo sapiens







145 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33034275 Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach. 2022 Mar 2
2 34787842 1 H, 15 N and 13 C resonance assignments of the Q61H mutant of human KRAS bound to GDP. 2022 Apr 1
3 34920161 In silico comparative analysis of KRAS mutations at codons 12 and 13: Structural modifications of P-Loop, switch I&II regions preventing GTP hydrolysis. 2022 Feb 5
4 34988297 Biochemical characterization of the interaction between KRAS and Argonaute 2. 2022 Mar 1
5 35053550 A Breakthrough Brought about by Targeting KRASG12C: Nonconformity Is Punished. 2022 Jan 13 1
6 35075146 KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge. 2022 Jan 25 2
7 35105836 Gaussian network model revisited: effects of mutation and ligand binding on protein behavior. 2022 Mar 7 1
8 35142321 Predicting the conformational variability of oncogenic GTP-bound G12D mutated KRas-4B proteins at zwitterionic model cell membranes. 2022 Feb 24 4
9 35158284 Discovery of ARS-1620 analogs as KRas G12C inhibitors with high in vivo antitumor activity. 2022 Apr 3
10 35202574 Regulation of GTPase function by autophosphorylation. 2022 Mar 3 1
11 35267628 Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance. 2022 Mar 4 2
12 35297922 Identification of functional substates of KRas during GTP hydrolysis with enhanced sampling simulations. 2022 Mar 30 3
13 35425180 Q61 mutant-mediated dynamics changes of the GTP-KRAS complex probed by Gaussian accelerated molecular dynamics and free energy landscapes. 2022 Jan 5 3
14 35462078 Millisecond molecular dynamics simulations of KRas-dimer formation and interfaces. 2022 Apr 23 1
15 35463958 Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect. 2022 1
16 35586192 Free Energy Profiles Relating With Conformational Transition of the Switch Domains Induced by G12 Mutations in GTP-Bound KRAS. 2022 3
17 35614853 Structural and biophysical properties of farnesylated KRas interacting with the chaperone SmgGDS-558. 2022 May 25 2
18 35631410 Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRASG12C Inhibitors. 2022 May 8 1
19 33309163 Design, synthesis and pharmacological evaluation of bicyclic and tetracyclic pyridopyrimidinone analogues as new KRASG12C inhibitors. 2021 Mar 5 1
20 33680360 Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins. 2021 2
21 33723061 Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants. 2021 Mar 23 4
22 33739090 Mutation-Induced Impacts on the Switch Transformations of the GDP- and GTP-Bound K-Ras: Insights from Multiple Replica Gaussian Accelerated Molecular Dynamics and Free Energy Analysis. 2021 Apr 26 8
23 33744388 Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape. 2021 Jun 1 1
24 34237589 Residue interaction networks of K-Ras protein with water molecules identifies the potential role of switch II and P-loop. 2021 Aug 1
25 34345014 RNF141 interacts with KRAS to promote colorectal cancer progression. 2021 Sep 1
26 34347509 Cytotoxic activity of KRAS inhibitors in combination with chemotherapeutics. 2021 Sep 2
27 34551282 KARATE: PKA-induced KRAS4B-RHOA-mTORC2 supercomplex phosphorylates AKT in insulin signaling and glucose homeostasis. 2021 Nov 18 1
28 34570515 Conformational Fluctuations in GTP-Bound K-Ras: A Metadynamics Perspective with Harmonic Linear Discriminant Analysis. 2021 Oct 25 2
29 34625747 A structural model of a Ras-Raf signalosome. 2021 Oct 1
30 34703570 Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine-dependent interface: a model for KRAS oligomerization. 2021 Oct 6 2
31 32227412 Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement. 2020 Jun 26 2
32 32257057 The quaternary assembly of KRas4B with Raf-1 at the membrane. 2020 1
33 32486141 A H-REV107 Peptide Inhibits Tumor Growth and Interacts Directly with Oncogenic KRAS Mutants. 2020 May 30 1
34 32636302 The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2. 2020 Aug 21 1
35 32715349 Structure-based inhibitor design of mutant RAS proteins-a paradigm shift. 2020 Dec 2
36 33145412 GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf. 2020 Oct 28 4
37 33153459 Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors. 2020 Nov 5 4
38 33196710 [Therapeutic possibilities in KRAS-mutant lung adenocarcinoma]. 2020 Sep 23 2
39 33266473 Influence of Cholesterol on the Orientation of the Farnesylated GTP-Bound KRas-4B Binding with Anionic Model Membranes. 2020 Nov 22 1
40 30683722 Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction. 2019 Feb 12 2
41 30930748 Galectin-3 (MAC-2) Controls Microglia Phenotype Whether Amoeboid and Phagocytic or Branched and Non-phagocytic by Regulating the Cytoskeleton. 2019 1
42 31219673 Optical Control of the GTP Affinity of K-Ras(G12C) by a Photoswitchable Inhibitor. 2019 Dec 2 2
43 31306575 Intrinsic GTPase Activity of K-RAS Monitored by Native Mass Spectrometry. 2019 Aug 6 1
44 31339036 PIP2 Influences the Conformational Dynamics of Membrane-Bound KRAS4b. 2019 Aug 20 2
45 31409810 Oncogenic G12D mutation alters local conformations and dynamics of K-Ras. 2019 Aug 13 2
46 31611389 KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis. 2019 Oct 29 4
47 31827279 KRAS4A directly regulates hexokinase 1. 2019 Dec 2
48 31853358 Investigation of GTP-dependent dimerization of G12X K-Ras variants using ultraviolet photodissociation mass spectrometry. 2019 Sep 14 2
49 29229665 Ras and the Plasma Membrane: A Complicated Relationship. 2018 Oct 1 2
50 29313669 Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele. 2018 Feb 27 3